Therapeutic Goods (Standard for Human Albumin) (TGO 111) Order 2022
1Therapeutic Goods (Standard for Human Albumin) (TGO 111) Order 2022
Start here
Get a plain-English read of 1
Turn the raw legal text into a practical explanation grounded in Therapeutic Goods (Standard for Human Albumin) (TGO 111) Order 2022.
meta-content-style-type: text/css meta-content-type: application/xhtml+xml; charset=utf-8 meta-generator: Aspose.Words for .NET 22.10.0
?xml version="1.0" encoding="utf-8" standalone="no"?>
Commonwealth Coat of Arms of Australia
Therapeutic Goods (Standard for Human Albumin) (TGO 111) Order 2022
I, Nick Henderson, as delegate of the Minister for Health and Aged Care, make the following order.
Dated 25 March 2022
Nick Henderson
First Assistant Secretary Medicines Regulation Division Health Products Regulation Group Department of Health
Contents
1 Name
2 Commencement
3 Authority
4 Definitions
5 Standard
6 Application
7 Requirements
8 Repeals
Schedule 1—Repeals
Therapeutic Goods Order No. 90 Standard for human albumin
1 Name
(1) This instrument is the Therapeutic Goods (Standard for Human Albumin) (TGO 111) Order 2022.
(2) This instrument may also be cited as TGO 111.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
- Commencement information
- Column 1 Column 2 Column 3
- Provisions Commencement Date/Details
-
- The whole of this instrument 31 March 2022. 31 March 2022
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 10 of the Therapeutic Goods Act 1989.
4 Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) British Pharmacopoeia;